Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
RG-7827 by F. Hoffmann-La Roche for Solid Tumor: Likelihood of Approval
RG-7827 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Solid Tumor. According to GlobalData,...
RG-7827 by F. Hoffmann-La Roche for Non-Small Cell Lung Cancer: Likelihood of Approval
RG-7827 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Non-Small Cell Lung Cancer. According...
RG-7827 by F. Hoffmann-La Roche for Metastatic Colorectal Cancer: Likelihood of Approval
RG-7827 is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Metastatic Colorectal Cancer. According to...